Citations

Showing 10 of 108083 citations.

External globus pallidus input to the dorsal striatum regulates habitual reward-seeking behavior
Hong, Sa‐Ik , Yang, Minsu Abel , Essa, Hesham , Choi, Doo‐Sup , Choi, Doo-Sup , Baker, Matthew , Kang, Seungwoo , Song, Minryung , Peyton, Lee , Lee, Sang Wan

Mayo Clinic

No container title available | November 17, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2210532/v1 Get It

Abstract The external globus pallidus (GPe) coordinates action-selection through GABAergic projections throughout the basal ganglia. GPe arkypallidal (arky) neurons project exclusively to the dorsal striatum, which regulates goal-directed and habitual reward-seeking. However, the role of GPe arky neurons in reward-seeking remains unknown. Here, we identified that a majority of arky neurons target the dorsolateral striatum (DLS). Using fiber photometry, we found that arky activities were higher during random interval (RI; habit) compared to random ratio (RR; goal) operant reward-seeking. Support vector machine analysis demonstrated that arky neuron activities have sufficient information to distinguish between RR and RI behavior. Genetic ablation of this arkyGPe◊DLS circuit facilitated a shift from goal-directed to habitual behavior. Conversely, chemogenetic activation reduced habitual seeking-behaviors, which was blocked by systemic D1R agonism. Our findings reveal a novel role of this arkyGPe◊DLS circuit in constraining habitual reward-seeking, which is relevant to addictive behaviors and other compulsive disorders.
Characterizing the Effects of Annealing Temperature on Knitted Shape Memory Actuators
Pettys‐Baker, Robert, Subash, Niharikha , Mack, Isidora, Shah, Surbhi , Abel, Julianna , Holschuh, Brad

Mayo Clinic

ASME 2022 Conference on Smart Materials, Adaptive Structures and Intelligent Systems | November 17, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1115/smasis2022-90779 Get It

Abstract Advancements in the design of knitted Shape Memory Alloy (SMA) actuators have produced highly functional and easy-to-wear advanced textiles with variable fit/stiffness properties. Annealing SMA at high temperatures can alter their thermomechanical properties; however, heat treatments of SMA knitted actuators have yet to be systematically studied. This study investigates the relationship between annealing temperatures and the resultant SMA knit thermomechanical behavior (maximum force and actuator transformation temperature). Twelve SMA knitted samples were manufactured using Dynalloy Flexinol® 70°C (0.012″). Nine samples were annealed at three different temperatures (350°C, 450°C, 550°C), with the remaining samples acting as controls. The blocked force mechanical performance was characterized by varying the thermal load across various applied structural strains. The samples were thermally cycled between 20°C and 90°C at each strain level. The results indicate that samples annealed while stretched along the knit-course direction enabled large-force actuation at smaller displacements than the control samples. Annealed samples showed higher peak force than control samples as annealing temperature increased until the 450°C condition; however, the 550° samples showed a dip in force. The actuator transformation temperatures showed reduced Austenite start (As) temperature compared to the control sample, enabling actuation at a lower temperature while also reducing the Martensite Finish (Mf) temperatures. This work allows for greater tuning of knitted SMA actuators to meet the needs of researchers and product developers.
Favorable Outcomes in Older Recipients Receiving Simultaneous Pancreas Kidney Transplantation
Budhiraja, Pooja , Heilman, Raymond L. , Reddy, Kunam S. , Khamash, Hassan A., Ninan, Jacob, Reddy, Swetha , Me, Hay Me , Misra, Suman , Katariya, Nitin , Katariya, Nitin N , Budhiraja, Pooja , Jadlowiec, Caroline C. , Chakkera, Harini A.

Mayo Clinic

Transplantation Direct | November 17, 2022 | Volume: 8 | Issue: 12 | Pages: e1413

10.1097/txd.0000000000001413 | PMID 36406897 Get It

Background. The objective of this study was to compare the long-term outcomes of older (50–65 y) type 1 diabetics with body mass index <35 kg/m2 and type 2 diabetics with body mass index <30 kg/m2 who received simultaneous pancreas kidney transplantation (SPKT) versus living donor kidney transplants (LDKTs). All subjects had insulin-dependent diabetes. Methods. This is a retrospective single-center study from July 2003 to March 2021 with a median follow-up of 7.5 y. Results. There were 104 recipients in the SPKT and 80 in the LDKT group. The mean age was 56 y in SPKT and 58 y in LDKT. There were 55% male recipients in the SPKT group versus 75% in LDKT. The duration of diabetes was 32 y in SPKT versus 25 y in LDKT. The number of preemptive transplants and length of dialysis were similar. However, the wait time was shorter for LDKT (269 versus 460 d). Forty-nine percent of the LDKT recipients received the organ within 6 mo of being waitlisted compared with 28% of SPKT recipients (P = 0.001). Donor age was lower in the SPKT group (27 versus 41 y). The estimated 5-y death censored kidney survival was 92% versus 98%, and 5-y patient survival was 86% versus 89% for SPKT versus LDKT. Death censored kidney and patient survival, acute kidney rejection by 1 y, and BK viremia were similar between the 2 groups. There were 17 pancreas graft losses within 1 y of transplant, the majority related to surgical complications, and it was not associated with increased mortality. Conclusions. SPKT in selected recipients aged 50 and above can have excellent outcomes similar to LDKT recipients.
Salivary Biomarker Evaluation of Chronic Pancreatitis Patients Reveals Alterations in Human Proteins, Cytokines, Prostaglandin E2 Levels, and Bacterial Diversity
Waldron, Richard T. , Jones, Elaina K. , Anani, Vincent, Hines, Jolaine M., Lugea, Aurelia, Diniz, Márcio A. , Kim, Sungjin , Habtezion, Aida , Hoffman, Kristi L. , Petrosino, Joseph F. , Fisher, William E., Li, Liang , Lennon, Ryan J. , Vege, Santhi Swaroop , Topazian, Mark , Zhao, Jing , Singh, Ravinder Jit, Diniz, Marcio A , Waldron, Richard T , Zhao, Jing , Lennon, Ryan J. , Singh, Ravinder J. , Pandol, Stephen J.

Mayo Clinic

Pancreas | November 17, 2022 | Volume: 51 | Issue: 7 | Pages: 723-732

10.1097/mpa.0000000000002113 | PMID 36395395 Get It

Objectives Chronic pancreatitis (CP) is a chronic fibroinflammatory condition of the pancreas difficult to diagnose in early stages. Novel biomarkers useful to facilitate early diagnosis or treatment responses may be found in biofluids. Although saliva can be easily and noninvasively collected from patients, useful salivary biomarkers from CP patients have not yet been identified. Methods Here, we analyzed the proteome by quantitative proteomics, cytokine/chemokine levels by Luminex analysis, prostaglandin E2 (PGE2) levels by a mass spectrometry-based assay, and bacterial species diversity by 16S ribosomal ribonucleic acid sequencing in saliva samples from confirmed CP patients and healthy controls. Results Our results indicate the presence of various differentially expressed proteins, cytokines/chemokines, and a loss of oral bacterial diversity in the saliva of CP patients. The PGE2 levels trend toward elevation in CP patients. Area under the receiver operating characteristic curve models for proteomic, cytokine, and PGE2 assays ranged from 0.59 to 0.90. Conclusions Collectively, our studies identify a range of putative CP biomarkers and alterations in human saliva requiring further validation. The biomarker discovery approaches we used might lead to identification of biomarkers useful for CP diagnosis and monitoring.
Pharmacotherapeutic options for pancreatic ductal adenocarcinoma
Sardar, Muhammad , Recio‐Boiles, Alejandro , Mody, Kabir , Karime, Christian , Chandana, Sreenivasa R , Mahadevan, Daruka , Starr, Jason S. , Jones, Jeremy , Jones, Jeremy C , Borad, Mitesh J. , Babiker, Hani M.

Mayo Clinic

Expert Opinion on Pharmacotherapy | November 17, 2022 | Volume: 23 | Issue: 18 | Pages: 2079-2089

10.1080/14656566.2022.2149322 | PMID 36394449 Get It

Perioperative Immune Checkpoint Inhibition in Early-Stage Non–Small Cell Lung Cancer
Desai, Aakash , Adashek, Jacob J. , West, Howard , Desai, Aakash P , Reuss, Joshua E. , Mansfield, Aaron S.

Mayo Clinic

JAMA Oncology | November 17, 2022 | Volume: 9 | Issue: 1 | Pages: 135

10.1001/jamaoncol.2022.5389 | PMID 36394834 Get It

Importance Although cancer-related mortality continues to decline, lung cancer remains the No. 1 cause of cancer deaths in the US. Almost half of the patients with non–small cell lung cancer (NSCLC) are diagnosed with early-stage, local or regional disease and are at high risk of recurrence within 5 years of diagnosis. Observations Immune checkpoint inhibitors (ICIs) have improved outcomes for patients with metastatic NSCLC and have recently been tested in multiple clinical trials to determine their efficacy in the neoadjuvant or adjuvant setting for patients with local or regional disease. The landscape for perioperative ICIs in lung cancer is evolving rapidly, with recently reported and soon to mature clinical trials; however, the recent data highlight the potential of ICIs to increase response rates and decrease rates of relapse in early stages of lung cancer. Concurrently, novel applications of cell-free DNA may guide perioperative management strategies. Conclusions and Relevance This article reviews the various approaches of incorporating perioperative use of immunotherapeutic agents for the treatment of early stages of NSCLC.
Changes in Glomerular Volume, Sclerosis, and Ischemia at 5 Years after Kidney Transplantation: Incidence and Correlation with Late Graft Failure
Đenić, Aleksandar , Bogojevic, Marija , Subramani, Rashmi , Smith, Byron H. , Alexander, Mariam P., Grande, Joseph P. , Kukla, Aleksandra , Bentall, Andrew , Alexander, Mariam P. , Smith, Byron , Alexander, Mariam P , Grande, Joseph P , Kukla, Aleksandra , Bentall, Andrew , Rule, Andrew D , Denic, Aleksandar , Park, Walter D. , Schinstock, Carrie A. , Rule, Andrew D. , Stegall, Mark D.

Mayo Clinic

Journal of the American Society of Nephrology | November 17, 2022 | Volume: 34 | Issue: 2 | Pages: 346-358

10.1681/asn.2022040418 | PMID 36396330 Get It

Significance Statement Glomerular volume, ischemic glomeruli, and global glomerulosclerosis are not consistently assessed on kidney transplant biopsies. The authors evaluated morphometric measures of glomerular volume, the percentage of global glomerulosclerosis, and the percentage of ischemic glomeruli and assessed changes in these measures over time to determine whether such changes predict late allograft failure. All three features increased from transplant to five-year biopsy. Kidneys with smaller glomeruli at 5 years had more global glomerulosclerosis and a higher percentage of ischemic-appearing glomeruli. Smaller glomeruli and increasing percentages of global glomerulosclerosis and ischemic glomeruli at 5 years predicted allograft failure. Only increased percentage of ischemic glomeruli predicted allograft failure at 5 years independent of all Banff scores. Glomerular changes reflect pathologic processes that predicted allograft loss; measuring them quantitatively might enhance the current Banff system and provide biomarkers for intervention trials. Background Histology can provide insight into the biology of renal allograft loss. However, studies are lacking that use quantitative morphometry to simultaneously assess changes in mean glomerular volume and in the percentages of globally sclerosed glomeruli (GSG) and ischemic-appearing glomeruli in surveillance biopsies over time to determine whether such changes are correlated with late graft failure. Methods We used digital scans of surveillance biopsies (at implantation and at 1 and 5 years after transplantation) to morphometrically quantify glomerular volume and the percentages of GSG and ischemic-appearing glomeruli in a cohort of 835 kidney transplants. Cox proportional hazards models assessed the risk of allograft failure with these three glomerular features. Results From implantation to 5 years, mean glomerular volume increased by nearly 30% (from 2.8×10 6 to 3.6×10 6 µm 3 ), mean percentage of GSG increased from 3.2% to 13.2%, and mean percentage of ischemic-appearing glomeruli increased from 0.8% to 9.5%. Higher percentages of GSG and ischemic-appearing glomeruli at 5-year biopsy predicted allograft loss. The three glomerular features at 5-year biopsy were related; the percentage of GSG and the percentage of ischemic glomeruli were positively correlated, and both were inversely correlated to glomerular volume. At 5 years, only 5.3% of biopsies had ≥40% ischemic glomeruli, but 45% of these grafts failed (versus 11.6% for <40% ischemic glomeruli). Higher Banff scores were more common with increasing percentages of GSG and ischemia, but at 5 years, only the percentage of ischemic glomeruli added to predictive models adjusted for Banff scores. Conclusions Glomerular changes reflect important pathologic processes that predict graft loss. Measuring glomerular changes quantitatively on surveillance biopsies, especially the proportion of ischemic-appearing glomeruli, may enhance the current Banff system and be a useful surrogate end point for clinical intervention trials. Podcast This article contains a podcast at
Increasing socioeconomically disadvantaged patients’ engagement in breast cancer surgery decision-making through a shared decision-making intervention (A231701CD): protocol for a cluster randomised clinical trial
Schumacher, Jessica R. , Zahrieh, David M. , Chow, Selina , Wills, Rachel, Hanlon, Bret M. , Tucholka, Jennifer L. , Neuman, Heather B. , Hanlon, Bret M , Neuman, Heather B , Taylor, John, Rathouz, Paul J.

Mayo Clinic

BMJ Open | November 17, 2022 | Volume: 12 | Issue: 11 | Pages: e063895

10.1136/bmjopen-2022-063895 | PMID 36396308 Get It

Introduction Socioeconomic disparities for breast cancer surgical care exist. Although the aetiology of the observed socioeconomic disparities is likely multifactorial, patient engagement during the surgical consult is critical. Shared decision-making may reduce health disparities by addressing barriers to patient engagement in decision-making that disproportionately impact socioeconomically disadvantaged patients. In this trial, we test the impact of a decision aid on increasing socioeconomically disadvantaged patients’ engagement in breast cancer surgery decision-making. Methods and analysis This multisite randomised trial is conducted through 10 surgical clinics within the National Cancer Institute Community Oncology Research Program (NCORP). We plan a stepped-wedge design with clinics randomised to the time of transition from usual care to the decision aid arm. Study participants are female patients, aged ≥18 years, with newly diagnosed stage 0–III breast cancer who are planning breast surgery. Data collection includes a baseline surgeon survey, baseline patient survey, audio-recording of the surgeon–patient consultation, a follow-up patient survey and medical record data review. Interviews and focus groups are conducted with a subset of patients, surgeons and clinic stakeholders. The effectiveness of the decision aid at increasing patient engagement (primary outcome) is evaluated using generalised linear mixed-effects models. The extent to which the effect of the decision aid intervention on patient engagement is mediated through the mitigation of barriers is tested in joint linear structural equation models. Qualitative interviews explore how barriers impact engagement, especially for socioeconomically disadvantaged women. Ethics and dissemination This protocol has been approved by the National Cancer Institute Central Institutional Review Board, and Certificate of Confidentiality has been obtained. We plan to disseminate the findings through journal publications and national meetings, including the NCORP network. Our findings will advance the science of medical decision-making with the potential to reduce socioeconomic health disparities. Trial registration number ClinicalTrials.gov Registry (NCT03766009).
Incidence and Epidemiology of Symptomatic Capitellar Osteochondritis Dissecans of the Elbow: A United States Population–Based Study Over a 25-Year Period
Uvodich, Mason E. , Braig, Zachary V. , Reinholz, Anna K., Till, Sara E., O'Driscoll, Shawn W., Sanchez-Sotelo, Joaquin, O’Driscoll, Shawn W. , Morrey, Mark E. , Sánchez‐Sotelo, Joaquín , Camp, Christopher L.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | November 17, 2022 | Volume: 10 | Issue: 11 | Pages: No page available

10.1177/23259671221135933 | PMID 36419473 Get It

Background: There are limited data on the incidence of capitellar osteochondritis dissecans (OCD) in the United States (US) population. Purpose: To determine the incidence of symptomatic capitellar OCD in a representative US subpopulation and identify changes in its incidence over time and to investigate the relationship between the incidence of capitellar OCD and patient sex and age. Study Design: Descriptive epidemiology study. Methods: A retrospective review was performed of patients aged ≤24 years from Olmsted County, Minnesota, with symptomatic capitellar OCD over a 25-year period (1995-2019). Patients with acute osteochondral injuries, Panner disease, and hereditary arthropathy were excluded. Poisson regression was utilized to identify the predictors of a capitellar OCD diagnosis. Incidence rates (per 100,000) were assessed for changes over time. Age groups of younger (10-15 years) versus older (16-24 years) patients were compared. Results: A total of 45 patients (78% male) were identified. The mean age was 14.5 years (range, 10-24 years); 31 patients were in the younger group, and 14 patients were in the older group. Sport participation was seen in 89%of patients; 90% were overhead athletes, and 58% were throwing athletes. The incidence of capitellar OCD was 6.0 per 100,000 overall, 9.5 per 100,000 for male patients, and 2.6 per 100,000 for female patients. The incidence was highest for male patients in the younger group (15.3/100,000) and lowest for female patients in the older group (0.8/100,000). The estimated incidence rate ratio for younger versus older patients was 3.3 ( P < .001), and the incidence rate ratio for male versus female patients was 3.5 ( P < .001). There were no changes in the incidence of capitellar OCD over time as a continuous or 5-year categorical variable ( P = .290 and P = .460, respectively). Overall, 82% of patients were treated surgically. There were no significant changes in surgical rates over time. Conclusion: In this US subpopulation, the overall incidence of symptomatic capitellar OCD between the ages of 10 and 24 years was 6.0 per 100,000 over the 25-year period studied, which is higher than previously reported US estimates. Incidence rates and treatment strategies did not change significantly over time.
Testicular cavernous hemangioma masquerading as testicular malignancy
Isharwal, Sumit , Khot, Rachita , Gupta, Srishti , Tandon, Yasmeen K.

Mayo Clinic

Journal of Clinical Ultrasound | November 17, 2022 | Volume: 51 | Issue: 5 | Pages: 898-900

10.1002/jcu.23399 | PMID 36385617 Get It